Understanding Kenyan policymakers’ perspectives about the introduction of new maternal vaccines
Health Policy and Planning · 2025
DOI: 10.1093/heapol/czae059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Policy and Planning, 2025. Verfasst von Rupali J Limaye und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD 21205, United States. Hauptthemen laut MEDLINE: Health Policy, Administrative Personnel, Immunization Programs, Policy Making. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
New vaccine policy adoption is a complex process, especially in low-and-middle-income countries, requiring country policymakers to navigate challenges such as competing priorities, human and financial resource constraints, and limited logistical capacity. Since the beginning of the Expanded Programme on Immunization, most new vaccine introductions under this structure have not been aimed at adult populations. The majority of adult vaccines offered under the Expanded Programme on Immunization are not typically tested among and tailored for pregnant persons, except those that are specifically recommended for pregnancy. Given that new maternal vaccines, including respiratory syncytial virus and group B streptococcus vaccines, are on the horizon, it is important to understand what barriers may arise during the policy development and vaccine introduction process. In this study, we sought to understand information needs among maternal immunization policymakers and decision-makers in Kenya for new vaccine maternal policy adoption through in-depth interviews with 20 participants in Nakuru and Mombasa, counties in Kenya. Results were mapped to an adapted version of an established framework focused on new vaccine introduction in low-and-middle-income countries. Participants reported that the policy process for new maternal vaccine introduction requires substantial evidence as well as coordination among diverse stakeholders. Importantly, our findings suggest that the process for new maternal vaccines does not end with the adoption of a new policy, as intended recipients and various actors can determine the success of a vaccine programme. Previous shortcomings, in Kenya, and globally during human papillomavirus vaccine introduction, show the need to allocate adequate resources in education of communities given the sensitive target group. With maternal vaccines targeting a sensitive group—pregnant persons—in the pipeline, it is an opportune time to understand how to ensure successful vaccine introduction with optimal acceptance and uptake, while also addressing vaccine hesitancy to increase population benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD 21205, United States.
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, 415 N Washington Street, Baltimore, MD 21205, United States.
- National Vaccines and Immunization Program, Ministry of Health Kenya, Afya House, Cathedral Road, P. O. Box 43319-00100, Nairobi, Kenya.
- Jhpiego Kenya, 2nd Floor, Arlington Block, 12 Riverside, off Riverside Drive, P.O. Box 66119-00800, Nairobi, Kenya.
ORCID-Profile: Rupali J Limaye, Berhaun Fesshaye, Prachi Singh, Emily Miller
Förderung
- Bill and Melinda Gates Foundation
Zitieren
APA
Limaye, R. J., Fesshaye, B., Singh, P., Jalang'o, R., Njogu, R. N., Miller, E., Schue, J., Sauer, M., Lee, C., & Karron, R. A. (2025). Understanding Kenyan policymakers’ perspectives about the introduction of new maternal vaccines. Health Policy and Planning. https://doi.org/10.1093/heapol/czae059
Vancouver
Limaye RJ, Fesshaye B, Singh P, Jalang'o R, Njogu RN, Miller E, et al. Understanding Kenyan policymakers’ perspectives about the introduction of new maternal vaccines. Health Policy and Planning. 2025. doi:10.1093/heapol/czae059
BibTeX
@article{Limaye2025,
author = {Limaye, Rupali J and Fesshaye, Berhaun and Singh, Prachi and Jalang'o, Rose and Njogu, Rosemary Njura and Miller, Emily and Schue, Jessica and Sauer, Molly and Lee, Clarice and Karron, Ruth A},
title = {Understanding Kenyan policymakers’ perspectives about the introduction of new maternal vaccines},
journal = {Health Policy and Planning},
year = {2025},
doi = {10.1093/heapol/czae059}
}
EUVIMED